Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC BioMed Acquires Exclusive Rights to Clone Shipper in Canada, Negotiations Continue for Complete Acquisition - Video News Alert on InvestmentPitch.com

C.THC

Vancouver, British Columbia--(Newsfile Corp. - November 2, 2016) - THC BioMed International (CSE: THC) (OTC Pink: THCBF) (FSE: TFHC) has entered into an exclusive distribution agreement with Clone Shipper, for the rights to clone shipper products in Canada, paying $75,000 for the distribution rights for a two-year period.

InvestmentPitch.com has produced a "video news alert" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "THC BioMed" in the search box. It is also available on YouTube (click here).



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_obol38cy/THC-BioMed-CSE-THC-entered-into-an-exclusive-distribution-agreement-with-Clone-Shipper

The two companies are continuing to move forward to close the THC BioMed acquisition of Clone Shipper for US$1 million, which was announced in the recent Letter of Intent. Management believes this acquisition will allow THC to penetrate the U.S. and international cannabis markets, in the areas where it is legally permissible.

US-based Clone Shipper specializes in packaging products used to transport live plants and is currently the only device that meets Canadian and Federal International laws governing the transportation of controlled live plants. The patented design allows for an LED light to keep the clone in the growing vegetative stage for 12 to 24 hours while being shipped.

The company also sells Clonex clone solution, a specifically formulated plant food for rooting clones and seedlings using a profile of the highest quality minerals including nitrogen, phosphorus and calcium along with vitamin B1 which reduces the risk of transplant shock.

John Miller, President and CEO, stated: "In order to meet immediate demand for the product, we have entered into this distribution agreement so that Clone Shipper is made available to the Canadian market place. THC has injected USD$ 75,000 into Clone Shipper for general working capital and to have subtle changes made to the design of the device to ensure it meets regulatory requirements. Clone Shipper is an essential component required to be able to transport controlled, live plants in compliance with regulatory requirements. Clone Shipper ensures your plants arrive healthy and stress free."

Clone Shipper products are currently available for purchase on www.cloneshipper.com, and as of December 1st, 2016, they will be available for purchase on www.THCbiomed.com.

The products are also available at gardening supply outlets throughout the US, and on popular internet sites such as Amazon.com.

Management believes that Clone Shipper is currently the only device that meets Canadian and International laws governing the transportation of controlled, live plants, and that demand will continue to increase with the legalization of medical cannabis. The company plans to continue to strengthen patents on the Clone Shipper product.

Health Canada previously granted THC authorization, through a wholly-owned subsidiary, to produce fresh marijuana, cannabis oil, and cannabis resin. The company also carries a diverse selection of seeds, imported from Holland, including high CBD and high THC producing strains.

The shares are trading at $0.96 and with 101 million shares currently outstanding, the company is capitalized at $97 million.

For more information, please visit www.THCbiomed.com, contact John Miller, President & CEO, at 604-682-1643 or email info@THCbiomed.com.

About InvestmentPitch Media

InvestmentPitch Media is arguably the largest producer and distributer of video news content, primarily for small and mid-cap companies. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today